Stockscreener 앱 받기
1.31
5.65%
0.07
전일 마감가:
$1.24
열려 있는:
$1.23
하루 거래량:
816.39K
Relative Volume:
0.49
시가총액:
$212.79M
수익:
$400.57M
순이익/손실:
$9.21M
주가수익비율:
32.75
EPS:
0.04
순현금흐름:
$146.36M
1주 성능:
+13.42%
1개월 성능:
+33.33%
6개월 성능:
-14.94%
1년 성능:
-71.08%
1일 변동 폭
$1.23
$1.32
1주일 범위
$1.05
$1.32
52주 변동 폭
$0.5271
$5.1288
아이언우드 제약 Stock (IRWD) Company Profile
명칭
Ironwood Pharmaceuticals Inc
전화
617-621-7722
주소
100 SUMMER STREET, SUITE 2300, BOSTON, MA
IRWD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
1.31 | 186.80M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
아이언우드 제약 Stock (IRWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-04-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | 개시 | Leerink Partners | Market Perform |
| 2024-08-08 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | 개시 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Wells Fargo | Overweight |
| 2023-11-09 | 개시 | Jefferies | Buy |
| 2023-09-28 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-02 | 개시 | CapitalOne | Overweight |
| 2022-04-22 | 개시 | Piper Sandler | Overweight |
| 2020-09-30 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | 개시 | Northland Capital | Outperform |
| 2019-07-10 | 재개 | Credit Suisse | Neutral |
| 2019-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | 업그레이드 | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-11-07 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-07-23 | 개시 | H.C. Wainwright | Sell |
| 2018-05-09 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2017-07-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-05-03 | 개시 | Wells Fargo | Outperform |
| 2017-04-07 | 재확인 | Mizuho | Buy |
| 2017-02-22 | 재확인 | Barclays | Equal Weight |
| 2016-11-04 | 재확인 | Mizuho | Buy |
| 2016-10-24 | 재확인 | Wedbush | Neutral |
| 2016-10-10 | 재확인 | Mizuho | Buy |
| 2016-09-27 | 재확인 | WallachBeth | Hold |
모두보기
아이언우드 제약 주식(IRWD)의 최신 뉴스
Jacobs Levy Equity Management Inc. Sells 2,042,706 Shares of Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat
Zacks Research Has Bearish Estimate for IRWD Q3 Earnings - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Invesco Ltd. Sells 246,735 Shares of Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat
Analysts Offer Predictions for IRWD Q2 Earnings - MarketBeat
Voleon Capital Management LP Buys 787,901 Shares of Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat
Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Share Price Boosted 33% But Its Business Prospects Need A Lift Too - simplywall.st
Nuveen LLC Makes New Investment in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat
Candlestick Signal Suggests Reversal in Ironwood Pharmaceuticals Inc.2025 Earnings Surprises & Capital Efficient Trade Techniques - beatles.ru
Ironwood Pharmaceuticals Inc. Flashes Rebound Signal in Oversold ConditionJuly 2025 Drop Watch & Technical Confirmation Alerts - beatles.ru
What are Ironwood Pharmaceuticals Inc.’s recent SEC filings showingJuly 2025 Technicals & Technical Entry and Exit Tips - خودرو بانک
Is Ironwood Pharmaceuticals Inc. likely to announce a buybackJuly 2025 Gainers & AI Powered Market Entry Strategies - خودرو بانک
Ironwood Pharmaceuticals, Inc. $IRWD Shares Sold by Russell Investments Group Ltd. - MarketBeat
Is Ironwood Pharmaceuticals Inc. stock a good pick for beginnersJuly 2025 Sector Moves & Intraday High Probability Setup Alerts - خودرو بانک
When is the best time to exit Ironwood Pharmaceuticals Inc.Weekly Investment Summary & Risk Adjusted Buy/Sell Alerts - Newser
Comparing Ironwood Pharmaceuticals Inc. in custom built stock radarsQuarterly Trade Report & Safe Entry Zone Tips - Newser
Zacks Research Issues Pessimistic Forecast for IRWD Earnings - MarketBeat
Using Ichimoku Cloud for Ironwood Pharmaceuticals Inc. technicalsMarket Sentiment Report & Daily Momentum Trading Reports - Newser
Combining price and volume data for Ironwood Pharmaceuticals Inc.2025 Trading Recap & Daily Stock Trend Reports - Newser
Measuring Ironwood Pharmaceuticals Inc.’s beta against major indicesMarket Activity Report & Safe Entry Momentum Tips - Newser
Can Ironwood Pharmaceuticals Inc. recover in the next quarter2025 Price Targets & Long Hold Capital Preservation Tips - Newser
How hedge fund analytics apply to Ironwood Pharmaceuticals Inc. stock2025 Key Lessons & Weekly Top Gainers Trade List - Newser
Why Did Ironwood Pharmaceuticals Stock Plunge 17.74%? - AInvest
Is Ironwood Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Outlook & Fast Entry and Exit Trade Plans - Newser
Earnings visualization tools for Ironwood Pharmaceuticals Inc.Watch List & Stepwise Entry and Exit Trade Signals - Newser
Is Ironwood Pharmaceuticals Inc.’s growth already priced inWeekly Stock Report & Safe Entry Momentum Tips - خودرو بانک
Should you hold or exit Ironwood Pharmaceuticals Inc. now2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - Newser
Ironwood Pharma Regains Nasdaq Compliance - TipRanks
Will Ironwood Pharmaceuticals Inc. benefit from rate cutsJuly 2025 Update & Free Risk Controlled Daily Trade Plans - خودرو بانک
Ironwood Pharmaceuticals Inc. stock trendline breakdownQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
Published on: 2025-09-03 06:20:24 - Newser
Published on: 2025-09-03 04:31:42 - Newser
Ironwood Pharmaceuticals Inc. stock chart pattern explainedEarnings Summary Report & Risk Managed Investment Signals - Newser
Is Ironwood Pharmaceuticals Inc. stock entering bullish territoryMarket Sentiment Review & Weekly Hot Stock Watchlists - Newser
Will Ironwood Pharmaceuticals Inc. stock recover after recent drop2025 Winners & Losers & Risk Managed Investment Strategies - Newser
Published on: 2025-09-02 07:32:33 - خودرو بانک
Using data models to predict Ironwood Pharmaceuticals Inc. stock movementWeekly Profit Analysis & Technical Confirmation Alerts - Newser
What indicators show strength in Ironwood Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Tips - Newser
What Fibonacci levels say about Ironwood Pharmaceuticals Inc. reboundExit Point & AI Driven Price Predictions - Newser
Published on: 2025-08-31 13:49:26 - beatles.ru
RSI Reset May Fuel Rebound in Ironwood Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Risk adjusted return profile for Ironwood Pharmaceuticals Inc. analyzedPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Options Data Show Bullish Bias in Ironwood Pharmaceuticals Inc.July 2025 Rallies & Safe Entry Trade Reports - beatles.ru
아이언우드 제약 (IRWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
아이언우드 제약 주식 (IRWD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| John Minardo | Chief Legal Officer |
Aug 11 '25 |
Sale |
0.84 |
7,754 |
6,513 |
400,378 |
| Martini Gregory S. | Chief Financial Officer |
Aug 11 '25 |
Sale |
0.84 |
1,265 |
1,063 |
182,545 |
| Silver Ronald | Principal Accounting Officer |
Aug 11 '25 |
Sale |
0.84 |
2,846 |
2,391 |
276,809 |
2.67%
0.04%
자본화:
|
볼륨(24시간):